Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
Oncotarget|November 22, 2017
Impact of mismatch-repair deficiency on the colorectal cancer immune microenvironmentYingyi Zhang, Zhao Sun, Xinxin Mao, et al.
Thoracic Cancer|May 27, 2024
Genomic and T cell repertoire biomarkers associated with malignant mesothelioma survivalMuwen Nie, Zhao Sun, Ningning Li, et al.
Aging and Disease|October 11, 2021
HIF-1α promotes the migration and invasion of cancer-associated fibroblasts by miR-210Ying Yang, Junjie Gu, Xuechun Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 15, 2024
Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trialMeixi Liu, Chao Ren, Haiqiong Zhang, et al.
Cancer Letters|July 26, 2011
A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancerLin Zhao, Chunmei Bai, Yajuan Shao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2026
Preclinical and First-in-Human Study of Carbonic Anhydrase IX-Targeting Theranostic Pair, [68Ga]Ga/[177Lu]Lu-NYM096, in Clear Cell Renal Cell CarcinomaJingnan Wang, Xinchun Yan, Meixi Liu, et al.
Frontiers in Oncology|July 30, 2021
Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203)Chun Han, Sisi Ye, Chunhong Hu, et al.
Bioorganic Chemistry|April 22, 2022
Design, synthesis and biological evaluation of novel FAK inhibitors with better selectivity over IR than TAE226Tao Chen, Yan Liu, Jiang Liu, et al.
NPJ Science of Food|June 24, 2026
DNA methylation, transcriptomic, and metabolomic analyses provide new mechanistic insights into cold shock-induced chilling tolerance in cucumberYiting Ren, Jianlou Mu, Yunxiang Wang, et al.
Neuroendocrinology|September 9, 2025
Circulating Tumor DNA Profiling Identifies Actionable Mutations as Prognostic Markers in Advanced Neuroendocrine TumorsNa Zhou, Guofeng Zhao, Yang Gao, et al.
Pageof 17